Adial Pharmaceuticals Inc (ADIL): Next-Year EPS Estimate 52.66%
As of 2026-06-11, Adial Pharmaceuticals Inc (ADIL) has a next-year EPS growth estimate of 52.66%.
On 2026-05-13, analyst consensus for ADIL's next-year EPS growth shifted from 56.76% to 52.66% — a negative change of 4.10 percentage points. The revised estimate has been sustained across 22 subsequent trading sessions. Current-year growth is projected at 55.91%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 52.66%
- EPS growth this year
- 55.91%
- EPS next quarter (est)
- -$1.06
- Last price
- $2.98
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 52.66% | 55.91% | -$1.06 | $2.98 |
| 2026-06-10 | 52.66% | 55.91% | -$1.06 | $2.16 |
| 2026-06-09 | 52.66% | 55.91% | -$1.06 | $2.13 |
| 2026-06-08 | 52.66% | 55.91% | -$1.06 | $2.21 |
| 2026-06-07 | 52.66% | 55.91% | -$1.06 | $2.21 |
| 2026-06-04 | 52.66% | 55.91% | -$1.06 | $2.42 |
| 2026-06-03 | 52.66% | 55.91% | -$1.06 | $2.32 |
| 2026-06-02 | 52.66% | 55.91% | -$1.06 | $2.36 |
| 2026-06-01 | 52.66% | 55.91% | -$1.06 | $2.45 |
| 2026-05-31 | 52.66% | 55.91% | -$1.06 | $2.40 |
| 2026-05-28 | 52.66% | 55.91% | -$1.06 | $2.53 |
| 2026-05-27 | 52.66% | 55.91% | -$1.06 | $2.39 |
| 2026-05-26 | 52.66% | 55.91% | -$1.06 | $2.24 |
| 2026-05-25 | 52.66% | 55.91% | -$1.06 | $2.08 |
| 2026-05-24 | 52.66% | 55.91% | -$1.06 | $2.08 |
| 2026-05-21 | 52.66% | 55.91% | -$1.06 | $2.30 |
| 2026-05-20 | 52.66% | 55.91% | -$1.06 | $2.35 |
| 2026-05-19 | 52.66% | 55.91% | -$1.06 | $2.06 |
| 2026-05-18 | 52.66% | 55.91% | -$1.06 | $1.61 |
| 2026-05-17 | 52.66% | 55.91% | -$1.06 | $1.38 |
| 2026-05-14 | 52.66% | 55.91% | -$1.06 | $1.36 |
| 2026-05-13 | 52.66% | 55.91% | -$1.06 | $1.43 |
| 2026-05-12 | 56.76% | 49.79% | -$1.30 | $1.38 |
| 2026-05-11 | 57.65% | 48.74% | -$2.73 | $1.44 |
| 2026-05-10 | 57.65% | 48.74% | -$2.73 | $1.43 |
| 2026-05-07 | 57.65% | 48.74% | -$2.73 | $1.42 |
| 2026-05-06 | 57.65% | 48.74% | -$2.73 | $1.58 |
| 2026-05-05 | 57.65% | 48.74% | -$2.73 | $1.60 |
| 2026-05-04 | 57.65% | 48.74% | -$2.73 | $1.60 |
| 2026-05-03 | 57.65% | 48.74% | -$2.73 | $1.55 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Adial Pharmaceuticals Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Adial Pharmaceuticals Inc (ADIL) has a next-year EPS growth estimate of 52.66%, based on analyst consensus.
When was the latest EPS estimate revision for ADIL?▾
The most recent revision occurred on 2026-05-13, when analysts adjusted the next-year EPS growth estimate from 56.76% to 52.66%.
What sector and industry does Adial Pharmaceuticals Inc belong to?▾
Adial Pharmaceuticals Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ADIL appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Adial Pharmaceuticals Inc (ADIL) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports